By
Source Medpagetoday
Investigational transcranial magnetic stimulation that targeted a brain network involved in memory slowed progression in mild-to-moderate Alzheimer’s disease, data from a small phase II study suggested.
At 1 year, noninvasive personalized stimulation of the default mode network (DMN) led to an estimated mean change of 1.3 points on the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB), compared with 2.4 points for sham treatment (P=0.038), reported Giacomo Koch, MD, PhD, of the University of Ferrara in Italy at the Clinical Trials on Alzheimer’s Diseaseopens in a new tab or window annual meeting in Madrid.
CDR-SB scores — the primary outcome in this single-center study — range from 0 to 18, with higher scores indicating greater impairment.
Read more https://www.medpagetoday.com/meetingcoverage/ctad/112719